TABLE 2.
Variables | r | SE | p | (β) 95% CI |
---|---|---|---|---|
BMI (kg/m2) | −0.082 | 0.032 | 0.012 | (0.865 ~ 0.982) |
DM family history | 2.957 | 0.286 | <0.0001 | (10.9838 ~ 33.692) |
Fatty liver | 0.069 | 0.248 | 0.962 | (0.659 ~ 1.740) |
MLR | −8.270 | 1.237 | <0.0001 | (0.0001 ~ 0.003) |
PHR | 0.004 | 0.001 | 0.001 | (1.002 ~ 1.007) |
ALT (U/L) | 0.003 | 0.003 | 0.285 | (0.999 ~ 1.010) |
AST (U/L) | 0.005 | 0.007 | 0.483 | (0.991 ~ 1.019) |
eGFR (ml/min/1.73 m2) | 0.063 | 0.006 | <0.0001 | (1.053 ~ 1.077) |
TC/HDL‐C | 0.185 | 0.099 | 0.042 | (0.991 ~ 1.460) |
TG/HDL‐C | −0.201 | 0.057 | <0.0001 | (0.731 ~ 0.915) |
RC (mmol/L) | 1.269 | 0.275 | <0.0001 | (2.076 ~ 3.092) |
WHR | 0.179 | 0.023 | <0.0001 | (1.143 ~ 1.251) |
SBP (mm Hg) | 0.050 | 0.012 | <0.0001 | (1.028 ~ 1.076) |
DBP (mm Hg) | 0.054 | 0.014 | <0.0001 | (0.922 ~ 0.974) |
Abbreviations: ALT, alanine aminotransferase; AST, aspartic transaminase; BMI, body mass index; CI, confidence interval; DBP, diastolic blood pressure; DM, diabetes mellitus; eGFR, estimated glomerular filtration rate; HDL‐C, high‐density lipoprotein cholesterol; MLR, monocyte to lymphocyte ratio; PHR, platelet/HDL‐C ratio; RC, remnant cholesterol; SBP, systolic blood pressure; T2DM, type 2 diabetes mellitus; TC/HDL‐C, TC/HDL‐C ratio; TG/HDL‐C, TG/HDL‐C ratio; WHR, waist‐to‐hip ratio.